
Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. (AMPE) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AMPE · as of Jun 8, 2026
Key Statistics
Explore Ampio Pharmaceuticals, Inc. Data
ampe stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
ampe competitorsStock Performance
Full HistoryAbout Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipel…
what is ampio pharmaceuticals, inc. · ampe stock overview · ampio pharmaceuticals, inc. company profile · who is ampio pharmaceuticals, inc. ceo · ampe OTC · ampio pharmaceuticals, inc. headquarters · ampio pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Ampio Pharmaceuticals, Inc. (AMPE) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 31, 2010. As of the latest trading session, AMPE stock price is $0.18, with a market capitalization of $207,884. The stock has returned +40.36% over the past 12 months and +3421.15% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Ampio Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2023, Ampio Pharmaceuticals, Inc. reported revenue of — and net income of -$8.6M. For detailed data — including Ampio Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Ampio Pharmaceuticals, Inc. (AMPE) stock price is $0.18. The stock is traded on OTC under the ticker symbol AMPE. The 52-week range is $0.00 – $0.64.